References
- Anderson R M, Donnelly C A, Ferguson N M, Woolhouse M E J, Watt C J, Udy H J, MaWhinney S, Dunstan S P, Southwood T R E, Wilesmith J W. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996; 382: 779–788
- Bessen R A, Kocisko D A, Raymond G H, Nandan S, Lansbury P T, Caughey B. Non‐genetic propagation of strain‐specific properties of scrapie prion protein. Nature 1995; 375: 698–700
- Bruce M E, Dickinson A G. Biological evidence that scrapie has an independent genome. J Gen Virol 1987; 68: 79–89
- Bruce M E. Scrapie strain variation and mutation. Br Med Bull 1993; 49: 822–838
- Diringer H, Blode H, Oberdieck U. Virus‐induced amyloidosis in scrapie involves a change in covalent linkage in the preamyloid. Arch Virol 1991; 118: 127–131
- Dron M, Manuelidis L. Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt‐Jakob Disease by representational difference analysis. J Neurovirol 1996; 2: 240–248
- Lasemezas C, Deslys J ‐P, Demaimay R, Adjou K, Lamoury F, Dormont D, Robain O, Ironside J, Hauw J ‐J. BSE transmission to macaques. Nature 1996; 381: 733–734
- Lewis D L, Arens M. Resistance of microorganisms to disinfection in dental and medical devices. Nature Medicine 1995; 1: 956–958
- Manuelidis E E, Gorgacz E J, Manuelidis L. Viremia in experimental Creutzfeldt‐Jakob disease. Science 1978; 200: 1069–1071
- Manuelidis L, Sklaviadis T, Manuelidis E E. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt‐Jakob disease. EMBO J 1987; 6: 341–347
- Manuelidis L. The dimensions of Creutzfeldt‐Jakob Disease. Transfusion 1994; 34: 915–928
- Manuelidis L, Sklaviadis T, Akowitz A, Fritch W. Viral particles are required for infection in neurodegenerative Creutzfeld‐Jakob Disease. Proc Natl Acad Sci USA 1995; 92: 5124–5128
- Manuelidis L, Fritch W. Infectivity and host responses in Creutzfeldt‐Jakob Disease. Virology 1996; 215: 46–59
- McKinnon D J. Thirty new cases of Hepatitis B found. All had EEGs at six clinics, officials say. Toronto Star. 1996; SC4
- Oken R, McGeer P. Letter to the editor. J Dental Res 1995; 74: 1836
- Prusiner S B. Molecular biology of prion diseases. Science 1991; 252: 1515–1522
- Riesner D, Kellings K, Wiese U, Wulfert M, Mirenda C, Prusiner S B. Disruption of prion rods generates 10‐nm spherical particles having high a‐helical content and lacking scrapie infectivity. J Virol 1996; 70: 1714–1722
- Rizza C R, Fletcher M L, Kernoff P B. Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of UK Haemophilia Centre Directors. Br J Haematol 1983; 84: 269–272
- Will R, Ironside J, Zeidler M, Cousens S, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith P. A new variant of Creutzfeldt‐Jakob Disease in the UK. Lancet 1996; 347: 921–925
- Xi Y G, Ingrosso A, Ladogana A, Masullo C, Pocchiari M. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 1992; 356: 598–601